Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (18501)	2/2/1999 3:48:00 PM
From: VLAD	Respond to of 23519

martin, I already returned an e-mail asking for specific individual licensing dates. If you want to ask more questions you can e-mail him at: Jim.Cuttle@pain.se.ast.... Let us know if he answers any questions you send and I'll let you know if I hear about the licenses.

To: Mkilloran who wrote (18501)	2/2/1999 5:40:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

martin, According to that e-mail from the Astra rep., MUSE licensing is not the responsibility of Astra. To me this means that it has been Vivus' responsibility to file the appropriate paper work for individual licensing. The next question is whether or not Vivus has done a poor job in filing timely paper work to individual countries or perhaps they have filed all needed paper work in a timely matter and they are simply waiting for each individual country to grant the license. If that's the case then Vivus really can not do anything except wait for individual licensing approvals from Germany, France, Italy and Spain in order to receive its 8 million dollars in milestone payments. As I said before, I think Wilson was being very conservative in his time line on European approvals and launches. I expect that we may see all 4 of these countries give MUSE licensing before the end of the quarter. IMO the next big thing to watch will be Astra's analyst meeting to be held in New York in 2 weeks. Astra may have some important things to say regarding Vivus and MUSE and certainly will have a lot to say regarding their merger with Zeneca.